While MBL levels and frequency of MBL and FCN2 polymorphisms were similar in controls and the entire SSc cohort, our preliminary data indicate that MBL deficiency (and potentially FCN2 mutations) might be a protective factor for the development of diffuse SSc. The gene discussed is MBL2; the disease is hyperinsulinemic hypoglycemia, familial, 4.